Nalaganje...
The safety profile of drotrecogin alfa (activated)
Continued safety assessment is essential for any newly approved therapy. Drotrecogin alfa (activated; DrotAA), which is approved for use in severe sepsis, has undergone clinical trials with corresponding safety analyses since 1995. However, the only comprehensive review of all trials is that reporte...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2007
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2230610/ https://ncbi.nlm.nih.gov/pubmed/18269693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc6157 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|